Prognostic value of baseline HRQOL for survival for 11 types of cancer pointed out by EORTC study

Results of an EORTC study published in Cancer point out the prognostic value of baseline recorded health-related quality of life for survival for eleven types of cancer: brain, breast, colorectal, esophageal, head and neck, lung, melanoma, ovarian, pancreatic, prostate, and testicular cancer. For each cancer site, at least one health-related quality of life parameter provided additional prognostic information over and above the clinical and sociodemographic variables.

Dr. Andrew Bottomley, EORTC Headquarters Associate Director says, "This study utilized a single standardized and validated patient self-assessment tool, the EORTC Core Quality of Life Questionnaire, or the QLQ-C30 for short. We selected thirty EORTC randomized controlled trials which involved eleven different cancer sites for this study. This effort included questionnaires completed by 7417 patients prior to their being randomized into one of these studies."

The health-related quality of life parameters that were found to be predictive for survival were: for brain cancer; , emotional functioning, global health status, and nausea and vomiting for ; physical functioning, nausea and vomiting, pain, and appetite loss for colorectal cancer; physical functioning and social functioning for esophageal cancer; emotional functioning, nausea and vomiting, and dyspnea for head and neck cancer; physical functioning and pain for lung cancer; physical functioning for melanoma; nausea and vomiting for ovarian cancer; global health status for pancreatic cancer; role functioning and appetite loss for prostate cancer; role functioning for .

Models were adjusted for age, sex, and World Health Organization performance status and were stratified by distant metastasis. For each cancer type, univariate and multivariate Cox proportional hazards modeling was used to assess the (P<.05) of 15 health-related quality of life parameters for each cancer site.


Explore further

Long-term finasteride doesn't impair quality of life

Journal information: Cancer

Provided by European Organisation for Research and Treatment of Cancer
Citation: Prognostic value of baseline HRQOL for survival for 11 types of cancer pointed out by EORTC study (2013, November 6) retrieved 20 June 2019 from https://medicalxpress.com/news/2013-11-prognostic-baseline-hrqol-survival-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more